LECLERCQ; Gabrielle
Patent Applications and Registrations
Patent applications and USPTO patent grants for LECLERCQ; Gabrielle.The latest application filed is for "prevention or mitigation of t-cell engaging agent-related adverse effects".
- LECLERCQ; Gabrielle - Zurich CH
- Leclercq; Gabrielle - Zuerich CH
- Leclercq; Gabrielle - Lausanne CH
| Patent | Date |
|---|---|
| Prevention Or Mitigation Of T-cell Engaging Agent-related Adverse Effects App 20220168418 - HAEGEL; Helene Cecile ; et al. | 2022-06-02 |
| Prevention or mitigation of T-cell bispecific antibody-related adverse effects App 20220088195 - Klein; Christian ; et al. | 2022-03-24 |
| Methods for modulating protein galactosylation profiles of recombinant proteins using peracetyl galactose Grant 11,118,208 - Jordan , et al. September 14, 2 | 2021-09-14 |
| Methods For Modulating Protein Galactosylation Profiles Of Recombinant Proteins Using Peracetyl Galactose App 20190153497 - JORDAN; MARTIN ; et al. | 2019-05-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 